journal article·2019Open access

Surgery-free injectable macroscale biomaterials for local cancer immunotherapy

Kewen Lei, Li Tang

Biomaterials Science· Volume 7· Issue 3

Abstract

Immunotherapy can harness the power of host's immune system to fight cancer. In the last few decades, tremendous progress has been made in this field, with remarkable clinical successes achieved consisting of a durable response in a fraction of patients. However, there are enormous challenges to extending this therapy to the majority of cancer patients while retaining minimal adverse effects. Local immunotherapy is a promising approach for concentrating immunomodulation in situ without systemic exposure, therefore minimizing systemic toxicities. More importantly, local immunomodulation can still lead to systemic effects that confer overall anticancer immunity to eradicate disseminated diseases. To facilitate these local immunotherapies, a wide range of biomaterials have been developed as delivery systems to protect the locally injected immune-related therapeutics and extend their retention. Surgery-free injectable macroscale biomaterials are one of the most promising classes of biomaterials developed to date, as they are suitable for minimally invasive injection with needles or catheters and form a biocompatible three-dimensional matrix in situ as a drug-depot for controlled local delivery. In this mini-review, we provide an overview of the recent advancements in applying injectable macroscale biomaterials in local cancer immunotherapy by highlighting some recent examples. We compare various injectable biomaterials with different gelation mechanisms and discuss their applications in the delivery of immunomodulators, immune cells, and cancer vaccines. We also discuss current challenges and provide a perspective for the future development of injectable macroscale biomaterials in cancer immunotherapy.
Source: openalex_inverted_index · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Graphene and Nanomaterials Applications · Nanoplatforms for cancer theranostics · 3D Printing in Biomedical Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Institute of Materials Science & Engineering

École polytechnique fédérale de Lausanne (EPFL)

Lausanne

Switzerland

Institute of Bioengineering

Funding

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung · Novartis Stiftung für Medizinisch-Biologische Forschung · École Polytechnique Fédérale de Lausanne

References (100+)

Show source-provided references
1. Khalil · Nat. Rev. Clin. Oncol. · 2016 · 13 · 27310.1038/nrclinonc.2016.25 ↗
2. Ribas · Science · 2018 · 359 · 135010.1126/science.aar4060 ↗
3. June · Science · 2018 · 359 · 136110.1126/science.aar6711 ↗
4. Boutros · Nat. Rev. Clin. Oncol. · 2016 · 13 · 47310.1038/nrclinonc.2016.58 ↗
5. Marabelle · Clin. Cancer Res. · 2014 · 20 · 174710.1158/1078-0432.CCR-13-2116 ↗
6. Kwong · Cancer Res. · 2013 · 73 · 154710.1158/0008-5472.CAN-12-3343 ↗
7. Demaria · OncoImmunology · 2013 · 2 · e2599710.4161/onci.25997 ↗
8. Wang · Nat. Mater. · 2018 · 17 · 76110.1038/s41563-018-0147-9 ↗
9. Hotaling · Annu. Rev. Biomed. Eng. · 2015 · 17 · 31710.1146/annurev-bioeng-071813-104814 ↗
10. Weiden · Nat. Rev. Immunol. · 2018 · 18 · 21210.1038/nri.2017.89 ↗
11. Wang · Adv. Mater. · 2017 · 29 · 1
12. Koshy · Curr. Opin. Biotechnol. · 2016 · 40 · 110.1016/j.copbio.2016.02.001 ↗
13. Fan · Adv. Funct. Mater. · 2018 · 28 · 1
14. Hasan · Adv. Sci. · 2015 · 2 · 110.1002/advs.201500122 ↗
15. Tan · Materials · 2010 · 3 · 174610.3390/ma3031746 ↗
16. B. L. Vernon , Injectable Biomaterials: Science and Applications , Woodhead Pub. , Oxford , 201110.1533/9780857091376 ↗
17. Smith · Mater. Technol. · 2015 · 30 · B26410.1080/10667857.2015.1104827 ↗
18. Li · Chem. Soc. Rev. · 2012 · 41 · 219310.1039/C1CS15203C ↗
19. Yu · Chem. Soc. Rev. · 2008 · 37 · 147310.1039/b713009k ↗
20. Kretlow · Adv. Drug Delivery Rev. · 2007 · 59 · 26310.1016/j.addr.2007.03.013 ↗
21. Van Tomme · Int. J. Pharm. · 2008 · 355 · 110.1016/j.ijpharm.2008.01.057 ↗
22. Stephan · Nat. Biotechnol. · 2015 · 33 · 9710.1038/nbt.3104 ↗
23. Park · Sci. Transl. Med. · 2018 · 10 · eaar191610.1126/scitranslmed.aar1916 ↗
24. Chew · Adv. Healthcare Mater. · 2017 · 6 · 160076610.1002/adhm.201600766 ↗
25. Singh · Adv. Mater. · 2014 · 26 · 653010.1002/adma.201402105 ↗
26. Cheng · Plast. Aesthetic Res. · 2016 · 3 · 9210.20517/2347-9264.2015.124 ↗
27. Lih · Prog. Polym. Sci. · 2015 · 44 · 2810.1016/j.progpolymsci.2014.10.004 ↗
28. Perrien · Spine J. · 2013 · 13 · 58010.1016/j.spinee.2013.02.029 ↗
29. Tchartchian · Arch. Gynecol. Obstet. · 2014 · 290 · 69710.1007/s00404-014-3251-3 ↗
30. Frederickson · Eur. Spine J. · 1996 · 5 · S710.1007/BF00298566 ↗
31. Bowman · Clin. Transl. Med. · 2018 · 7 · 610.1186/s40169-017-0180-3 ↗
32. Dong · Biomater. Sci. · 2015 · 3 · 93710.1039/C4BM00448E ↗
33. Appel · Chem. Soc. Rev. · 2012 · 41 · 619510.1039/c2cs35264h ↗
34. Du · Chem. Rev. · 2015 · 115 · 1316510.1021/acs.chemrev.5b00299 ↗
35. Ikeda · Nat. Chem. · 2014 · 6 · 51110.1038/nchem.1937 ↗
36. Shigemitsu · Nat. Nanotechnol. · 2018 · 13 · 16510.1038/s41565-017-0026-6 ↗
37. Jeong · Adv. Drug Delivery Rev. · 2012 · 64 · 15410.1016/j.addr.2012.09.012 ↗
38. Moon · Chem. Soc. Rev. · 2012 · 41 · 486010.1039/c2cs35078e ↗
39. Park · Acc. Chem. Res. · 2012 · 45 · 42410.1021/ar200162j ↗
40. Hong · ACS Appl. Mater. Interfaces · 2017 · 9 · 1156810.1021/acsami.7b02488 ↗
41. Liu · Acta Biomater. · 2018 · 73 · 10310.1016/j.actbio.2018.04.035 ↗
42. Li · Expert Opin. Drug Delivery · 2011 · 8 · 99110.1517/17425247.2011.581656 ↗
43. Klouda · Eur. J. Pharm. Biopharm. · 2015 · 97 · 33810.1016/j.ejpb.2015.05.017 ↗
44. X. Bi and A.Liang , In Situ-Forming Cross-linking Hydrogel Systems: Chemistry and Biomedical Applications , ed. S. B. Majee , ExLi4EvA , 1st edn, 2016 , vol. 6 , pp. 131–158
45. DeForest · Nat. Chem. · 2011 · 3 · 92510.1038/nchem.1174 ↗
46. Brown · Chem. Soc. Rev. · 2017 · 46 · 653210.1039/C7CS00445A ↗
47. Vega · Nat. Commun. · 2018 · 9 · 61410.1038/s41467-018-03021-5 ↗
48. Sridhar · Adv. Healthcare Mater. · 2015 · 4 · 70210.1002/adhm.201400695 ↗
49. Escobar · Macromolecules · 2017 · 50 · 735110.1021/acs.macromol.7b01246 ↗
50. Kumar · Mater. Today · 2010 · 13 · 4210.1016/S1369-7021(10)70202-9 ↗
51. Henderson · J. Mater. Chem. B · 2013 · 1 · 268210.1039/c3tb20280a ↗
52. Zhao · Nat. Commun. · 2018 · 9 · 278410.1038/s41467-018-04998-9 ↗
53. Koshy · Acta Biomater. · 2018 · 65 · 3610.1016/j.actbio.2017.11.024 ↗
54. Patil · Int. J. Pharm. Pharm. Sci. · 2012 · 4 · 30
55. Milling · Adv. Drug Delivery Rev. · 2017 · 114 · 7910.1016/j.addr.2017.05.011 ↗
56. Michot · Eur. J. Cancer · 2016 · 54 · 13910.1016/j.ejca.2015.11.016 ↗
57. Xie · Wiley Interdiscip. Rev.: Nanomed. Nanobiotechnol. · 2018 · 10 · 1
58. Li · Nanomedicine · 2016 · 12 · 139710.1016/j.nano.2016.01.009 ↗
59. Leach · Biomaterials · 2018 · 163 · 6710.1016/j.biomaterials.2018.01.035 ↗
60. Nishida · Nanomedicine · 2016 · 12 · 12310.1016/j.nano.2015.08.004 ↗
61. Yata · Biomaterials · 2017 · 146 · 13610.1016/j.biomaterials.2017.09.014 ↗
62. Nishikawa · Biomaterials · 2011 · 32 · 48810.1016/j.biomaterials.2010.09.013 ↗
63. Shirota · Vaccines · 2015 · 3 · 39010.3390/vaccines3020390 ↗
64. Bode · Expert Rev. Vaccines · 2011 · 10 · 49910.1586/erv.10.174 ↗
65. Loh · J. Mater. Chem. · 2011 · 21 · 224610.1039/c0jm03051a ↗
66. Li · Biomaterials · 2018 · 168 · 2410.1016/j.biomaterials.2018.03.044 ↗
67. Yu · Adv. Mater. · 2018 · 30 · 180152710.1002/adma.201801527 ↗
68. Ishii · Biomaterials · 2016 · 84 · 21010.1016/j.biomaterials.2016.01.029 ↗
69. Lv · Bioact. Mater. · 2018 · 3 · 11810.1016/j.bioactmat.2017.08.003 ↗
70. Fakhari · J. Pharm. Sci. · 2017 · 106 · 203710.1016/j.xphs.2017.04.041 ↗
71. Ueda · Acta Biomater. · 2016 · 29 · 10310.1016/j.actbio.2015.10.024 ↗
72. Wang · Sci. Transl. Med. · 2018 · 10 · eaan368210.1126/scitranslmed.aan3682 ↗
73. Koshy · Biomaterials · 2014 · 35 · 247710.1016/j.biomaterials.2013.11.044 ↗
74. Esensten · Annu. Rev. Pathol.: Mech. Dis. · 2017 · 12 · 30510.1146/annurev-pathol-052016-100304 ↗
75. Veluchamy · Front. Immunol. · 2017 · 8 · 63110.3389/fimmu.2017.00631 ↗
76. Newick · Annu. Rev. Med. · 2017 · 68 · 13910.1146/annurev-med-062315-120245 ↗
77. Mirzaei · Front. Immunol. · 2017 · 8 · 185010.3389/fimmu.2017.01850 ↗
78. Neelapu · Nat. Rev. Clin. Oncol. · 2018 · 15 · 4710.1038/nrclinonc.2017.148 ↗
79. Bonifant · Mol. Ther.–Oncolytics · 2016 · 3 · 1601110.1038/mto.2016.11 ↗
80. Brudno · Blood · 2016 · 127 · 332110.1182/blood-2016-04-703751 ↗
81. Neelapu · Nat. Rev. Clin. Oncol. · 2018 · 15 · 4710.1038/nrclinonc.2017.148 ↗
82. Hori · Biomaterials · 2009 · 30 · 675710.1016/j.biomaterials.2009.08.037 ↗
83. Hori · Biomaterials · 2008 · 29 · 367110.1016/j.biomaterials.2008.05.033 ↗
84. Wang · Biomaterials · 2014 · 35 · 220710.1016/j.biomaterials.2013.11.070 ↗
85. Park · Acta Biomater. · 2013 · 9 · 477910.1016/j.actbio.2012.08.033 ↗
86. Kurisawa · J. Mater. Chem. · 2010 · 20 · 537110.1039/b926456f ↗
87. Guerra · Theranostics · 2017 · 7 · 373210.7150/thno.20251 ↗
88. Oh · J. Controlled Release · 2017 · 259 · 11510.1016/j.jconrel.2017.03.028 ↗
89. Goswami · Cell. Immunol. · 2017 · 316 · 110.1016/j.cellimm.2017.04.005 ↗
90. Chanmee · Cancers · 2014 · 6 · 167010.3390/cancers6031670 ↗
91. Dehne · Curr. Opin. Pharmacol. · 2017 · 35 · 1210.1016/j.coph.2017.04.007 ↗
92. Xu · Acta Biomater. · 2015 · 26 · 2310.1016/j.actbio.2015.08.010 ↗
93. Cheng · Acta Biomater. · 2017 · 51 · 25810.1016/j.actbio.2017.01.060 ↗
94. Tsao · Biomacromolecules · 2014 · 15 · 265610.1021/bm500502n ↗
95. Elias · J. Controlled Release · 2015 · 208 · 7610.1016/j.jconrel.2015.03.003 ↗
96. Monette · Biomaterials · 2016 · 75 · 23710.1016/j.biomaterials.2015.10.021 ↗
97. O'Connor · J. Immunol. · 2012 · 189 · 133010.4049/jimmunol.1102757 ↗
98. Saitakis · eLife · 2017 · 6 · 110.7554/eLife.23190 ↗
99. Van Der Burg · Nat. Rev. Cancer · 2016 · 16 · 21910.1038/nrc.2016.16 ↗
100. Tabi · Adv. Drug Delivery Rev. · 2006 · 58 · 90210.1016/j.addr.2006.05.004 ↗